Quantcast
Last updated on April 18, 2014 at 13:47 EDT

Latest pulmonary atresia Stories

2014-02-05 08:30:39

ATLANTA, Feb. 5, 2014 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that 2013 fourth quarter and year end financial results will be released on Thursday, February 20, 2014. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson,...

2013-10-24 08:35:46

Third Quarter 2013 Results and Update Conference Call Scheduled for Tuesday, October 29, 2013 at 10:00 am ET ATLANTA, Oct. 24, 2013 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced that it received in the fourth quarter of 2013 a payment of $15.4 million for its 2,379,554 shares of Medafor, Inc. common stock associated with the closing of the acquisition of Medafor, Inc. Third...

2013-10-14 08:25:11

ATLANTA, Oct. 14, 2013 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that 2013 third quarter financial results will be released on Tuesday, October 29, 2013. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief...

2013-07-11 08:29:24

ATLANTA, July 11, 2013 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that 2013 second quarter financial results will be released on Thursday, July 25, 2013. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief...

2013-04-09 08:30:34

ATLANTA, April 9, 2013 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that 2013 first quarter financial results will be released on Tuesday, April 30, 2013. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief executive...

2013-01-31 08:30:28

ATLANTA, Jan. 31, 2013 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that 2012 fourth quarter and year end financial results will be released on Thursday, February 14, 2013. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and...

2012-10-01 23:01:51

More than 152 Zoloft Lawsuits Pending in U.S District Court, Eastern District of Pennsylvania, Allege Zoloft Caused Birth Defects when Ingested by Pregnant Women. Melville, NY (PRWEB) October 01, 2012 The Zoloft birth defect lawyers at Alonso Krangle LLP, a leading national law firm focused on fighting for the rights of serious personal injury victims, report that the federal litigation recently established for Zoloft birth defect lawsuits is moving forward, with the litigation´s next...

2012-06-14 10:23:17

ATLANTA, June 14, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device company focused on cardiac and vascular surgery, announced today that it has entered into a settlement agreement with CardioFocus, Inc. ending the outstanding patent dispute between CryoLife's wholly owned subsidiary, Cardiogenesis Corporation (acquired by CryoLife in May 2011), and CardioFocus that was pending in the United States District Court of Massachusetts. Under the terms of the settlement,...

2011-10-13 07:34:00

ATLANTA, Oct. 13, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that ValveXchange, Inc., a company in which CryoLife owns a minority interest, has completed the first three human implants with its novel Vitality(TM) two-part heart valve system. The surgeries were performed in Asuncion, Paraguay and took place on Sept. 26 and 27, 2011. Three men aged 49, 62 and 72 received...

2011-07-07 07:34:00

ATLANTA, July 7, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today a $3.5 million equity investment in ValveXchange® Inc. ValveXchange is a private medical device company that was spun-off out of Cleveland Clinic to develop a lifetime heart valve replacement technology platform featuring exchangeable bioprosthetic leaflets. Under the agreement, CryoLife will...